Nuveen Asset Management’s Acrivon Therapeutics ACRV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $80.7K | Sell |
13,402
-12,377
| -48% | -$74.5K | ﹤0.01% | 3302 |
|
|
2024
Q3 | $180K | Buy |
25,779
+13,958
| +118% | +$97.7K | ﹤0.01% | 3243 |
|
|
2024
Q2 | $68.6K | Hold |
11,821
| – | – | ﹤0.01% | 3316 |
|
|
2024
Q1 | $84.5K | Hold |
11,821
| – | – | ﹤0.01% | 3255 |
|
|
2023
Q4 | $58.2K | Hold |
11,821
| – | – | ﹤0.01% | 3303 |
|
|
2023
Q3 | $113K | Hold |
11,821
| – | – | ﹤0.01% | 3115 |
|
|
2023
Q2 | $153K | Buy |
+11,821
| New | +$153K | ﹤0.01% | 3118 |
|